Back to top

Image: Bigstock

Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings

Read MoreHide Full Article

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among the rest: earnings.

The earnings figure itself is key, of course, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb and vice versa.

Now that we know how important earnings and earnings surprises are, it's time to show investors how to take advantage of these events to boost their returns by utilizing the Zacks Earnings ESP filter.

The Zacks Earnings ESP, Explained

The Zacks Earnings ESP is more formally known as the Expected Surprise Prediction, and it aims to grab the inside track on the latest analyst estimate revisions ahead of a company's report. The idea is relatively intuitive as a newer projection might be based on more complete information.

The core of the ESP model is comparing the Most Accurate Estimate to the Zacks Consensus Estimate, where the resulting percentage difference between the two equals the Expected Surprise Prediction. The Zacks Rank is also factored into the ESP metric to better help find companies that appear poised to top their next bottom-line consensus estimate, which will hopefully help lift the stock price.

Bringing together a positive earnings ESP alongside a Zacks Rank #3 (Hold) or better has helped stocks report a positive earnings surprise 70% of the time. Furthermore, by using these parameters, investors have seen 28.3% annual returns on average, according to our 10 year backtest.

Most stocks, about 60%, fall into the #3 (Hold) category, and they are expected to perform in-line with the broader market. Stocks with a #2 (Buy) and #1 (Strong Buy) rating, or the top 15% and top 5% of stocks, respectively, should outperform the market, with Strong Buy stocks outperforming more than any other rank.

Should You Consider Alkermes?

The last thing we will do today, now that we have a grasp on the ESP and how powerful of a tool it can be, is to quickly look at a qualifying stock. Alkermes (ALKS - Free Report) holds a #3 (Hold) at the moment and its Most Accurate Estimate comes in at $0.47 a share 14 days away from its upcoming earnings release on February 15, 2024.

By taking the percentage difference between the $0.47 Most Accurate Estimate and the $0.43 Zacks Consensus Estimate, Alkermes has an Earnings ESP of +8.88%. Investors should also know that ALKS is one of a large group of stocks with positive ESPs. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

ALKS is just one of a large group of Medical stocks with a positive ESP figure. Tenet Healthcare (THC - Free Report) is another qualifying stock you may want to consider.

Tenet Healthcare, which is readying to report earnings on February 8, 2024, sits at a Zacks Rank #3 (Hold) right now. It's Most Accurate Estimate is currently $1.75 a share, and THC is seven days out from its next earnings report.

The Zacks Consensus Estimate for Tenet Healthcare is $1.55, and when you take the percentage difference between that number and its Most Accurate Estimate, you get the Earnings ESP figure of +13.1%.

ALKS and THC's positive ESP figures tell us that both stocks have a good chance at beating analyst expectations in their next earnings report.

Find Stocks to Buy or Sell Before They're Reported

Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Alkermes plc (ALKS) - free report >>

Tenet Healthcare Corporation (THC) - free report >>

Published in